What is Samsung Bioepis's contact information?

Samsung Bioepis's contact information: +82324556114.

How many employees does Samsung Bioepis have?

Samsung Bioepis has 1,600 employees.

What industry does Samsung Bioepis belong to?

Samsung Bioepis is in the industry of: Pharmaceuticals, Biotechnology, Healthcare.

What are Samsung Bioepis's official social media profiles?

Samsung Bioepis Linkedin Page Samsung Bioepis Twitter Page

What tech stack does Samsung Bioepis use?

Some of the popular technologies that Samsung Bioepis uses are: Outbrain, Google Analytics, jQuery, Swiper.

What are Samsung Bioepis's office addresses?

Samsung Bioepis has 2 known office addresses: Yeonsu-gu, Incheon 21987, KR Yeonsu-gu, Incheon 21987, Kr.

What is Samsung Bioepis's estimated annual revenue?

Samsung Bioepis's revenue is $500,000,000

What is Samsung Bioepis's open headcount?

Samsung Bioepis has no job postings yet.

What is the number of ad campaigns for Samsung Bioepis?

Samsung Bioepis has 12 advertisements.

What is the number of recent news articles about Samsung Bioepis?

Samsung Bioepis has 50 news articles.

Samsung Bioepis - Pubrio Company Profile & Intent

Samsung Bioepis

South Korea · Pharmaceuticals

Pharmaceuticals

Biotechnology

Healthcare

Established in 2012, Samsung Bioepis is a biopharmaceutical company committed to realizing healthcare that is accessible to everyone. Through innovations in product development and a firm commitment to quality, Samsung Bioepis aims to become the world's leading biopharmaceutical company. Samsung Bioepis continues to advance a broad pipeline of biosimilar candidates that cover a spectrum of therapeutic areas, including immunology, oncology and ophthalmology. For more information, please visit: www.samsungbioepis.com. To see our community guidelines, please visit: bit.ly/2l0yiI3

Company Insights

Category and Technology

Implementation Date

Last Recorded

Advertising
- Outbrain
  https://www.outbrain.com
  December 2, 2025
  -
Analytics
- Google Analytics
  https://marketingplatform.google.com/about/analytics/
  December 2, 2025
  -
JavaScript libraries
- jQuery
  https://jquery.com/
  December 2, 2025
  -
- Swiper
  https://swiperjs.com
  December 2, 2025
  -

Advertising
- Google AdSense
  https://www.google.com/adsense/start/
  August 2, 2025
  -
- Twitter Ads
  https://ads.twitter.com
  August 2, 2025
  -
- Amazon Advertising
  https://advertising.amazon.com
  August 2, 2025
  -
- Microsoft Advertising
  https://ads.microsoft.com
  August 2, 2025
  -
- Google Publisher Tag
  https://developers.google.com/publisher-tag/guides/get-started
  August 2, 2025
  -
- Prebid
  http://prebid.org
  August 2, 2025
  -
- DoubleClick Floodlight
  http://support.google.com/ds/answer/6029713?hl=en
  February 8, 2026
  -
- DoubleClick Campaign Manager (DCM)
  http://www.doubleclickbygoogle.com/solutions/digital-marketing/campaign-manager/
  August 2, 2025
  -
- ID5
  https://id5.io/
  August 2, 2025
  -

Get full access to view complete information

2026-01-28

Open job

Director, AI Enablement

Coindesk · London, England, United Kingdom

2025-09-05

Open job

Senior Security Operations Analyst

Coindesk · Frankfurt, Hesse, Germany

2025-10-08

Open job

News Reporter

Coindesk · Almada, Setúbal, Portugal

Get full access to view complete information

1 - 0 of 0

linkedin · Started 2/11/2026

Open ad

Inspirational Women in Science at Samsung Bioepis

Samsung Bioepis

linkedin · Started 2/5/2026

Globally, there are 19.3 million new cases of cancer every year — but cancer patients are more than just a statistic. Every patient’s experience with cancer is unique. Each person has a deeply personal story of resilience to tell. Compassion and empathy unite us all in the global fight against cancer. Let’s take early action wherever possible and raise the chances of the best health outcomes. #WorldCancerDay #UnitedByUnique ...

Samsung Bioepis

linkedin · Started 1/29/2026

At Samsung Bioepis, we value our alliances with leading industry partners, knowing they are critical to enacting meaningful change across the biosimilar landscape on a global scale.Jonathan Oh, our Director of Alliance Management, explains how we ensure the long-term success of our partnerships through effective governance. ...

Samsung Bioepis

linkedin · Started 2/13/2026

Open ad

Stellar’s Bet: Real-World Finance, Not Hype

Coindesk

linkedin · Started 1/1/2026

Coindesk

linkedin · Started 12/25/2025

Open ad

Position Your Brand at the Center of Web3

Coindesk

Get full access to view complete information

1 - 12 of 12

smedaily.co.kr · launches · 3 weeks ago

Open news

Samsung Bioepis settles Eylea patent, US launch expected

Samsung Bioepis settles Eylea patent dispute with Regeneron and Bayer, paving way for US launch of biosimilar Opuviz in January 2027.

Bayer

Regeneron

Samsung Bioepis

smedaily.co.kr · partners_with · 2026-01-30

Open news

Samsung Bioepis reaches patent agreement on Eylea biosimilar

Samsung Bioepis reached a patent agreement with Regeneron and Bayer for its Eylea biosimilar SB15, allowing launch in various regions from 2026.

Samsung Bioepis

asiae.co.kr · launches · 2026-01-28

Open news

Samsung Bioepis succeeds with PL strategy in US

Samsung Bioepis boosted sales by 23% using PBM private label strategy in US market, reducing reliance on milestone payments and strengthening core business competitiveness.

Samsung Bioepis

khgames.co.kr · is_developing · one week ago

Open news

Bitcoin option investors bet on downside despite price rise

Bitcoin ETF and crypto-holding firms are buying put options to hedge against potential price drops below $60,000, despite recent price increases.

Coindesk

Deribit

khgames.co.kr · is_developing · one week ago

Open news

Bitcoin's 'Death Cross' Appears: Future Trends?

Bitcoin chart shows 'death cross' pattern, historically preceding major price drops. Despite this, ETFs see $1 billion inflow and long-term investors continue accumulating.

Coindesk

Upbit Singapore

coinreaders.com · launches · one week ago

Open news

JPMorgan: Crypto Market Structure Act likely to pass mid-year

JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.

Coindesk

J.P. Morgan

Get full access to view complete information

1 - 25 of 50

Get full access to view complete information

Frequently Asked Questions Regarding Samsung Bioepis

Company Overview

2012

Founded

Pharmaceuticals

Industry

South Korea

Location

255,855

Ranking

1,600 employees

Size

Similar Companies

Get full access to view complete information

Company Insights

Advertising

Analytics

JavaScript libraries

Advertising

Frequently Asked Questions Regarding Samsung Bioepis

What is Samsung Bioepis's contact information?

How many employees does Samsung Bioepis have?

What industry does Samsung Bioepis belong to?

What does Samsung Bioepis do?

What are Samsung Bioepis's official social media profiles?

What tech stack does Samsung Bioepis use?

What are Samsung Bioepis's office addresses?

What is Samsung Bioepis's estimated annual revenue?

What is Samsung Bioepis's open headcount?

What is the number of ad campaigns for Samsung Bioepis?

What is the number of recent news articles about Samsung Bioepis?

Company Overview

Similar Companies

Frequently Asked Questions Regarding Samsung Bioepis

What is Samsung Bioepis's contact information?

How many employees does Samsung Bioepis have?

What industry does Samsung Bioepis belong to?

What does Samsung Bioepis do?

What are Samsung Bioepis's official social media profiles?

What tech stack does Samsung Bioepis use?

What are Samsung Bioepis's office addresses?

What is Samsung Bioepis's estimated annual revenue?

What is Samsung Bioepis's open headcount?

What is the number of ad campaigns for Samsung Bioepis?

What is the number of recent news articles about Samsung Bioepis?